Martin M?Enchbach - Profile and Investment Details

Investor Profile

Martin M?Enchbach is a Venture Capital based in Switzerland with a diverse investment portfolio that includes companies such as AM Pharma, Eyetech Pharmaceuticals, Moderna Therapeutics, Sonetik, VAXIMM, Radius Health, Palyon Medical, Abyrx, BioVascular, BioXell, Alpex Pharma, Binx Health, Auxilium Pharmaceuticals, Optimer Pharmaceuticals, Tioga Pharmaceuticals, Natural Dental Implants, Pevion Biotech, Orthocon, Aerovance, Lumavita, TargeGen, Aleva Neurotherapeutics, Vivoryon Therapeutics, Molecular Partners, Opsona. Over time, Martin M?Enchbach has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Martin M?Enchbach is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, DentalTech, Mobile, Manufacturing, Biotechnology, Genomics, Neuroscience, Health Diagnostics, Medical, Pharmaceuticals may find it worthwhile to explore potential connections with Martin M?Enchbach, as their portfolio suggests a familiarity and interest in this area.

Understanding Martin M?Enchbach’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.